Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MALACHITE INNOVATIONS, INC.

(MLCT)
SummaryQuotesChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Malachite Innovations, Inc. Announces Change of Corporate Headquarters

10/12/2021 | 09:00am EST

Malachite Innovations, Inc. announced that the company has moved corporate headquarters from Los Angeles, California to Cleveland, Ohio where many of the Company’s directors, officers and advisors are located. Additionally, Company's new corporate headquarters is intended to provide the Company with an attractive physical location to expand Company's organization in support of the anticipated growth of Company's Graphium Biosciences and Daedalus Ecosciences operations.


© S&P Capital IQ 2021
All news about MALACHITE INNOVATIONS, INC.
11/15MALACHITE INNOVATIONS, INC. Management's Discussion and Analysis of Financial Conditio..
AQ
11/15Malachite Innovations, Inc. Reports Earnings Results for the Second Quarter and Six Mon..
CI
10/12VITALITY BIOPHARMA : ADOPTS NEW NAME – MALACHITE INNOVATIONS, INC - Form 8-K
PU
10/12VITALITY BIOPHARMA, INC. : Entry into a Material Definitive Agreement, Amendments to Artic..
AQ
10/12VITALITY BIOPHARMA : Adopts New Name – Malachite Innovations, Inc.
GL
10/12Malachite Innovations, Inc. Announces Fiscal Year Change
CI
10/12Malachite Innovations, Inc. Announces Change of Corporate Headquarters
CI
10/12Malachite Innovations, Inc. has Changed its Ticker to MLCT from VBIO
CI
09/02Vitality Biopharma Announces Effective S-1 Registration Statement and DTC Eligibility
GL
09/02VITALITY BIOPHARMA : ANNOUNCES EFFECTIVE S-1 REGISTRATION STATEMENT AND DTC ELIGIBILITY (F..
PU
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -0,88 M - -
Net cash 2021 0,85 M - -
P/E ratio 2021 -10,4x
Yield 2021 -
Capitalization 15,4 M 15,4 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 3
Free-Float 66,9%
Chart MALACHITE INNOVATIONS, INC.
Duration : Period :
Malachite Innovations, Inc. Technical Analysis Chart | MLCT | US56089M1071 | MarketScreener
Income Statement Evolution
Managers and Directors
Michael Cavanaugh Chief Executive Officer & Director
Richard McKilligan Controller, Chief Financial & Accounting Officer
Edward F. Feighan Executive Chairman
Brandon Zipp Chief Science Officer
Richard F. Celeste Independent Director
Sector and Competitors
1st jan.Capi. (M$)
MALACHITE INNOVATIONS, INC.400.00%15
GILEAD SCIENCES, INC.20.61%88 146
BIONTECH SE326.89%84 049
REGENERON PHARMACEUTICALS33.17%67 266
WUXI APPTEC CO., LTD.24.40%64 416
VERTEX PHARMACEUTICALS-22.32%46 678